Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children’s Oncology Group study

Press/Media

Period	29 Feb 2024

Media coverage

Title	Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children’s Oncology Group study
Media name/outlet	ASHPublications.org
Country/Territory	United States
Date	29/02/24
URL	ct.moreover.com/?a=53215244237&p=1gw&v=1&x=AhTeMecfOVogrjYnGbc9AA
Persons	Birte Wistinghausen